Phase 2 Chemotherapy Induced Thrombocytopenia Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
Breast CancerGynecologic CancersOvarian Cancer+7 more
Peking University People's Hospital220 enrolled1 locationNCT07586826
Recruiting
Phase 2
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
Colorectal, CancerPancreatic CancerGastrointestinal Neoplasms+2 more
Peking University People's Hospital220 enrolled1 locationNCT07586813
Recruiting
Phase 2
Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients
Solid TumorsAdolescentChemotherapy Induced Thrombocytopenia+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT07043894
Recruiting
Phase 2
Romiplostim N01 for Chemotherapy-induced Thrombocytopenia
Chemotherapy Induced ThrombocytopeniaRomiplostim N01
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT07063225
Recruiting
Phase 2
Herombopag for Chemotherapy-induced Thrombocytopenia
Chemotherapy Induced ThrombocytopeniaHerombopag
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT05236582
Recruiting
Phase 2
Eltrombopag for Chemotherapy-induced Thrombocytopenia
Chemotherapy Induced ThrombocytopeniaEltrombopag
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT04600960
Recruiting
Phase 2
Avatrombopag for Chemotherapy-induced Thrombocytopenia
Chemotherapy Induced ThrombocytopeniaAvatrombopag
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT05218226